Figure 2 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study
Year: 2025
Type: other
Abstract: Evaluation of PD-1+ Treg cells and PD-1+CD8+ T cells. A and B, The scatter plots that show PD-1 positivity (%) in CD8+ T cells and Treg cells in patients with (A) NSCLC and (B) gastric cancer (GC). Straight line indicates PD-1 positivity (%) in CD8+ T cells/PD-1 positivity (%) in Treg cells of ≥1.
Authors: Kohei Shitara, Motohiro Tamiya, Kyoichi Okishio, Hisashi Hosaka, Katsunori Shinozaki, Nobuhiko Seki, Hiroki Hara, Yukiya Narita, Takeshi Shiraishi, Yosuke Tamura, Akihito Tsuji, Kunihiro Tsuji, Naohiro Watanabe, Hiroshi Tanaka, Toshifumi Yamaguchi, Kensei Yamaguchi, Hiroki Izumi, Yasunori Ushida, Hideaki Suna
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4415104614
Cites:
Cited by:
Related to: